Isobel d’Inverno

Walter Scott & Partners Ltd. (Walter Scott) is a wholly-owned investment management subsidiary of BNY Mellon International Asset Management Holdings No. 1 Ltd., itself a subsidiary of The Bank of New York Mellon Corp. (NYSE: BK) in the US. Headquartered in Edinburgh, the firm was founded by Walter G. Scott in 1983 to manage long-term equity portfolios for institutional investors around the world. Prior to October 2006 and the acquisition by Mellon Financial Corporation, Walter Scott was independently owned.

The Royal Edinburgh Military Tattoo Ltd. operates as a performing arts company. The Royal Edinburgh Military Tattoo Ltd. is based in Edinburgh, UK, and has subsidiaries in the UK. The British company was founded in 1990, and Jason Barrett has been the CEO of the company since 2023.

SIRAKOSS Ltd. develops medical devices. It focuses on synthetic Bone technology. The company was founded in October 2010 by Jordan Christopher Conway, Janet Mabel Scott Gibson, and Iain Ronald Gibson and is headquartered in Aberdeen, the United Kingdom.

Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.

Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom.

Inspiring Scotland engages in dealing and solving social problems for its people and communities. The company was founded by Helen Chambers in 2008 and is headquartered in Scotland, the United Kingdom.

Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom.

Center for Strategic & International Studies, Inc. provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector, and civil society. Its projects focus on areas such as AIDS, arms control, conflict resolution, NATO, the environment, immigration, intelligence, trade, health care, OPEC, space policy, and terrorism. The company was founded in 1962 by David M. Abshire and Admiral Arleigh Burke and is headquartered in Washington, DC.

Dundas Partners LLP (Dundas) is an independent asset management firm headquartered in Edinburgh, UK. The firm was founded by Alan McFarlane in 2010 and formerly known as Dundas Global Investors Ltd. Dundas offers portfolio management services directly to clients in separately managed accounts and indirectly through pooled investment vehicles. Their clients include: a US registered mutual fund, pooled investment vehicles, investment advisers, professional clients, institutional investors such as corporate pension and profit-sharing plans, endowment funds and other charitable organizations in Australia, New Zealand, the USA and UK.

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

MASA Life Science Ventures (MASA Life Science Venture) is a venture capital firm founded in 1994 by Andrew Sinclair Dunlop. The firm is headquartered in Bethesda, Maryland.

New Vantage Group LLC (New Vantage Group) is a venture capital firm founded in 1997 by John A. May. The firm is headquartered in McLean, Virginia.